Oncology Drugs to Watch 2022

Top 15 takeaways from ASCO 2022

As part of our Drugs to Watch™ program, Clarivate experts use proprietary data sources, landscape and event monitoring and deep market knowledge to identify key drug developments expected to have a significant impact on patients and markets.

This report explores treatment breakthroughs highlighted at ASCO 2022, the biggest oncology event of the year, and provide analysis on how they will reshape the landscape, along with analysis of some standout oncology therapeutics in the rapidly expanding Mainland China marketplace.

At Clarivate, our vision is to improve the way the world creates, protects and advances innovation. We can better understand the changing oncology landscape by leveraging our deep market expertise, data and insights solutions. Furthermore, our experts leverage a variety of proprietary data sources to advise clients on key trends and developments in the oncology space.

Download the report to access detailed insights.